Impact of performance status and age on osimertinib efficacy in patients with EGFR-mutant T790M-positive non-small-cell lung cancer
PDA clipping by video-assisted thoracoscopic surgery
Relationship between performance status or younger age and osimertinib therapy in T790M-positive NSCLC: are the available data convincing?
Bridging the gap: how do we improve long-term survival of locally-advanced esophageal cancer patients?
Respecting your elders: osimertinib demonstrates preferential activity in elderly patients with T790M positive non-small cell lung cancers
Impact of clinical features on the efficacy of osimertinib treatment in epidermal growth factor receptor mutant non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors due to T790M mutation
Does osimertinib treatment discriminate young patients?
Adjuvant chemotherapy for poor pathologic response after pre-operative chemoradiation in esophageal cancer: infeasible and illogical
Autopsy and clinical discrepancies in patients undergoing extracorporeal membrane oxygenation: a case series—a step towards understanding “Why”?
Randomized phase II trial reporting overall survival advantage by adding local consolidative therapy to systemic therapy for oligometastatic non-small cell lung cancer: another step forward on the long road of evidence-based medicine for oligometastatic disease
Optimal postoperative surveillance strategy in patients undergoing neoadjuvant chemoradiotherapy followed by surgery for esophageal carcinoma
Hyperprogressive disease with immunotherapy: new directions
Spread through air spaces in non-small cell lung cancer
Is no drain after thoracoscopic major resection for cancer acceptable?
Expanding the pool: the use of hepatitis C RNA positive organs in lung transplantation
Preoperative variables for predicting prolonged air leak following pulmonary resection
Challenge for establishment of international benchmarks for complications associated with esophagectomy
Safety of perioperative low dose aspirin therapy in major lung resection
No drain policy for “ultimate” enhanced recovery after surgery
Scar modification for polymorphic ventricular tachycardia and ventricular fibrillation: hope beyond trigger ablation?
Blood tumor mutational burden: are we ready for clinical implementation?
Local consolidative therapy in metastatic non-small cell lung cancer
Preoperative treatment of anemia—could an ultra-short-term multimodal approach be beneficial for patients undergoing lung surgery?
Optimal lung cancer screening intervals following a negative low-dose computed tomography result
The inadvertent compounding of misconceptions regarding the surgical treatment of atrial fibrillation in mitral valve patients
Potential advantage of digital drainage systems using a low-suction approach after video-assisted thoracoscopic surgery lobectomy
The prospective database on thymic epithelial tumours from the European Continent
Increasing T stage is associated with the need for more extensive lymph node assessment in clinical stage I non-small cell lung cancer
What you do not know, you do not recognize…and you do not improve future patient care…particularly in extracorporeal life support (ECLS) patients
Hybrid minimally invasive esophagectomy for esophageal cancer: less is more
Predicting spread through air spaces (STAS) preoperatively: can imaging help?
Expanding the donor pool for lung transplantation using HCV-positive donors
Role of chest tube drainage in physical function after thoracoscopic lung resection
Minimally invasive esophagectomy—behind patient-centered learning curves
PEEP titration guided by transpulmonary pressure: lessons from a negative trial
KEYNOTE-042 and the role for single agent pembrolizumab in patients with PD-L1 tumor proportion score 1–49%
Transcatheter edge-to-edge mitral valve repair in functional mitral regurgitation: patient selection according to MITRA-FR and COAPT
Lactate guided resuscitation—nothing is more dangerous than conscientious foolishness
A new approach to predicting risk for N2 disease in non-small cell lung cancer
What did the first meta-analysis of tumor spread through air spaces (STAS) bring to light?
Prolonged air leaks after vats lobectomy: do we need another risk score?
Radical consolidative treatments a hope for patients with oligometastatic non-small cell lung cancer
Intratumoral lymph vessel invasion as a predictive risk factor for nodal metastasis in non-small cell lung cancer: should L-1 status obligate adjuvant chemotherapy?
Demographic ageing and its influence on current lung transplant practice
Searching for an arrow hitting two targets: the time to evaluate long-term outcomes of video-assisted thoracoscopic surgery lobectomy for early-stage lung cancer
Less is more: the benefits of low suction for digital pleural drainage devices after pulmonary resection
Expanding the knowledge of oligometastatic disease—but uncertainties remain significant
Positive-end expiratory pressure titration and transpulmonary pressure: the EPVENT 2 trial
Pancreatic PCSK9 and its involvement in diabetes
Letter to the Editor
Chest ultrasound: enhanced recovery after surgery (ERAS) best friend in general thoracic surgery
Is chest ultrasonography an essential tool for the modern thoracic surgeon?
Chest ultrasound versatility in routinary to complicated cases: our perspective
Sex differences in the development of upper airway morphology: is this the new kid on the block?
Emphysema assessment for personalized immunotherapy response prediction in lung cancer patients
Albumin to fibrinogen ratio and fibrinogen to pre-albumin ratio are economical, simple and promising prognostic factors for solid malignancy
Chest ultrasound in post-operative management: the needed to rethink our perspective?
Pathologic complete response is not equivalent to cure in esophageal cancer
Heterogeneity of stage IIIA leads to difficulty in determining optimal treatment
The supplement was commissioned by the Editorial office, Journal of Thoracic Disease without any sponsorship or funding.